TruScreen Announcements
TruScreen Group Ltd is dual-listed on the NZX and ASX.
On this page, you can browse The Company’s NZX & ASX announcements.
Looking for news articles and press releases?
View News
Sort By:
Announcement
21.11.2024
November Newsletter
Announcement
21.11.2024
Germany’s Springer Nature Journal Publication on TruScreen
Announcement
21.11.2024
TruScreen Ranked in Top 6 Women’s Health Startups Globally
Announcement
21.11.2024
TruScreen is featured in a UNITAID report
Announcement
25.9.2024
TruScreen Appoints Dexter Cheung as Chair of Technology Committee
Announcement
25.9.2024
Results of Annual General Meeting
Announcement
25.9.2024
Annual Shareholders Meeting Presentation
Announcement
25.9.2024
TruScreen outperforms Pap Smear in Saudi Arabia Study
Announcement
25.7.2024
TruScreen Pty Ltd – Change of Operations Address
TruScreen has moved into a new office in Lane Cove West
Announcement
11.7.2024
TruScreen Commences Major Commercial Rollout in Vietnam
Commercial activities ramp up in Vietnam after the MOH listing of TruScreen 065c789v948zsw (1)
Announcement
5.7.2024
TruScreen Annual Report FY2024
TruScreen Annual Report and Finacial Statement for Finacial Year 2024 TRU Annual Report - FY2024
Announcement
14.12.2023
TruScreen Wins Top Prize in Poland’s Institute for Mother and Child Startup Challange
NZX | ASX - GENERAL
Announcement
13.12.2023
TruScreen included on the Vietnamese Ministry of Health Approved Technology List
NZX | ASX - MKTUPDATE
Announcement
6.11.2023
TruScreen Awarded Zimbabwe Tender
NZX | ASX - GENERAL
Announcement
6.11.2023
TruScreen Half Year Results
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
Announcement
6.11.2023
TruScreen Half Year Results Template
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
Announcement
20.10.2023
Appendix 2A
ASX - Appendix 2A
Announcement
20.10.2023
Appendix 3G
ASX - Appendix 2A
Announcement
20.10.2023
Capital Change Notice
NZX | ASX - SHINTR
Announcement
20.10.2023
Director and Officer Disclosure Notice
NZX | ASX - SHINTR
Announcement
12.10.2023
Strong Sales Growth in China in Improved Half Year Results
NZX | ASX - GENERAL
Announcement
18.9.2023
TruScreen – Commercial Breakthrough in Saudi Arabia
NZX | ASX - GENERAL
Announcement
29.8.2023
Shareholder Meeting Results
NZX | ASX - MEETING
Announcement
29.8.2023
Annual Meeting Presentation
NZX | ASX - MEETING
Announcement
16.8.2023
TruScreen Stakeholder Newsletter August 2023
NZX | ASX - GENERAL
Announcement
15.8.2023
Strong Sales growth in Q1 FY2024 (April to June 2023)
NZX | ASX - GENERAL
Announcement
2.8.2023
TruScreen Opto-electrical Technology Recognised
NZX | ASX - GENERAL
Announcement
28.7.2023
Truscreen Annual meeting Notice
NZX | ASX - MEETING
Announcement
17.7.2023
Director and Officer Change of Interest Notice
NZX | ASX - SHINTR
Announcement
30.6.2023
Annual Report FY2023
NZX | ASX - ANNREP
Announcement
30.5.2023
TruScreen Preliminary Final Results March 2023
NZX - FLLYR
Announcement
30.5.2023
TruScreen Preliminary Results March 2023 Announcement
NZX | ASX - FLLYR
Announcement
30.5.2023
TruScreen Preliminary Final Results Summary
NZX | ASX - FLLYR
Announcement
16.5.2023
CSCCP Cervical Cancer Screening Guideline to Include TruScreen Technology
NZX | ASX - GENERAL
Announcement
8.5.2023
TruScreen Recognised in Authoritative China Blue Paper
NZX | ASX - GENRAL
Announcement
8.5.2023
Director and Officer Change of Interest Notice
NZX | ASX - SHINTR
Announcement
1.5.2023
Growing Recognition for TruScreen
NZX | ASX - GENERAL
Announcement
24.3.2023
Director and Officer Disclosure Notices
NZX | ASX - SHINTR
Announcement
22.3.2023
Appendix 2A
ASX - Appendix 2A
Announcement
22.3.2023
Capital Change Notice
NZX - SHINTR
Announcement
21.3.2023
TruScreen Rights Offer closes
NZX | ASX - TRU
Announcement
13.3.2023
Outstanding Clinical Evaluation Results from Saudi Arabia
NZX | ASX - GENERAL
Announcement
13.3.2023
TruScreen Rights Issue Offer Closing Soon
NZX | ASX - OFFER
Announcement
9.3.2023
Publication of Research Report
NZX | ASX - GENERAL
Announcement
8.3.2023
China Ramps Up for Public Health Check Centres
NZX | ASX - GENERAL
Announcement
3.3.2023
TruScreen Raises $600,000 in Initial Share Placement
NZX | ASX - OFFER
Announcement
28.2.2023
TruScreen Rights Issue Offer Opens
NZX | ASX - OFFER
Announcement
24.2.2023
Pro Rata Renounceable Rights Issue Offer Document
NZS | ASZ - OFFER
Announcement
22.2.2023
TruScreen to Lodge a Pro Rata Renounceable Rights Issue
ASX | NZX - OFFER
Announcement
17.2.2023
Cleansing Notice
ASX | NZX - OFFER
Announcement
17.2.2023
TruScreen Corporate Action Notice
NZX | OFFER
Announcement
15.2.2023
Commercial Update
NZX | ASX - GENERAL
Announcement
19.12.2022
Market Update
ASX | NZX - GENERAL
Announcement
5.12.2022
Director and Officer Disclosure Notice – Mr Christopher Horn
NZX | ASX - SHINTR
Announcement
5.12.2022
Director and Officer Disclosure Notice – Mr Anthony Ho
NZX | ASX - SHINTR
Announcement
29.11.2022
TruScreen Half Year Results Template
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
Announcement
29.11.2022
TruScreen Half Year Results
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
Announcement
22.11.2022
TruScreen Market Update
NZX | ASX - GENERAL
Announcement
9.11.2022
TruScreen Stakeholder Newsletter November 2022
NZX | ASX - GENERAL
Announcement
2.11.2022
Hosts Global Medical Symposium, Expands Reach in Vietnam
NZX | ASX - GENERAL
Announcement
31.10.2022
Director and Officer Disclosure Notice
NZX | ASX - SHINTR
Announcement
10.10.2022
Director and Officer Disclosure Notice
NZX | ASX - SHINTR
Announcement
6.10.2022
Dr Beata Edling Appointed CEO of TruScreen Group
NZX | ASX - GENERAL
Announcement
6.9.2022
Shareholder Meeting Results
NZX | ASX - MEETING
Announcement
6.9.2022
Annual Meeting Presentation
NZX | ASX - MEETING
Announcement
1.9.2022
TRU Signs Five Year Manufacturing Agreement for SUS Supply
NZX | ASX - GENERAL
Announcement
15.8.2022
Director and Officer Disclosure Notice
NZX - SHINTR
Announcement
10.8.2022
Relaunch of TruScreen Devices in Xinjiang Uygur Region
NZX | ASX - GENERAL
Announcement
3.8.2022
TruScreen-based cervical cancer screening centre opens in Mexico City
NZX | ASX - GENERAL
Announcement
1.8.2022
TruScreen Shareholder Meeting
NZX | ASX - MEETING
Announcement
18.7.2022
TruScreen Director Nominations Closing Date
NZX | ASX - MEETING
Announcement
6.7.2022
SPH Notice – Waitara Trustees Limited
NZX - SHINTR
Announcement
5.7.2022
Director & Officer Disclosure Notice
NZX | ASX - SHINTR
Announcement
30.6.2022
Annual Report FY2022
NZX | ASX - ANNREP
Announcement
16.6.2022
Director & Officer Disclosure Notice
NZX | ASX - SHINTR
Announcement
14.6.2022
Director & Officer Disclosure Notice
NZX | ASX - SHINTR
Announcement
1.6.2022
Director & Officer Disclosure Notice
NZX | ASX - SHINTR
Announcement
30.5.2022
TruScreen FY22 Preliminary Results
NZX | ASX - FLLYR
Announcement
30.5.2022
Provision for Impairment of Non Current Assets
NZX | ASX - GENERAL
Announcement
5.4.2022
COGA Trial validates superiority of TruScreen cervical cancer screening method
NZX | ASX - MKTUPDATE
Announcement
4.3.2022
Capital Change Notice
NZX | ASX - SHINTR
Announcement
3.3.2022
TruScreen achieves significant milestones with Distributors
NZX | ASX - MKTUPDATE
Announcement
29.12.2021
Disclosure of Directors and Senior Managers Relevant Interests
NZX | ASX - SHINTR
Announcement
29.12.2021
Issue of Unlisted Options
NZX | ASX - SECISSUE
Announcement
15.12.2021
TruScreen Makes Progress in Key Markets Worldwide
NZX | ASX - General, Progress Report
Announcement
29.11.2021
Half Year Report September 2021
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
Announcement
29.11.2021
TruScreen Results Announcement Template September 2021
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
Announcement
29.11.2021
TruScreen September 2021 Results Announcement
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
Announcement
20.10.2021
TruScreen Device – Milestones Achieved on Growth Strategy
NZX | ASX - MKTUPDATE
Announcement
20.10.2021
Clinical Trial Results Highlight Efficacy of TRU Technology
NZX | ASX - GENERAL
Announcement
30.9.2021
Director and Officer Disclosure Notice
NZX | ASX - SHINTR
Announcement
22.7.2021
Ceasing to be Substantial Shareholder Browns Island Holdings Limited
NZX | ASX - SHINTR
Announcement
2.6.2021
Stakeholder Newsletter – May 2021
NZX | ASX - General | Periodic Reports - Other, Progress Report, Letter to Shareholders
Announcement
2.6.2021
Preliminary Final Report March 2021
NZX | ASX - FLLYR | Preliminary Final Report
Announcement
2.6.2021
Appendix 4E & Preliminary Final Results March 2021
ASX - Preliminary Final Report
Announcement
2.6.2021
Prelim Results FY2021
NZX - FLLYR
Announcement
31.5.2021
Preliminary Results Announcement
NZX | ASX - FLLYR | Preliminary Final Report
Announcement
4.3.2021
Final Director’s Interest Notice
NZX | ASX - SHINTR
Announcement
4.3.2021
Director and Officer Disclosure Notice
NZX | ASX - SHINTR
Announcement
2.3.2021
TruScreen Board Appointment
NZX | ASX - ADMIN
Announcement
26.2.2021
TruScreen Executive Leadership Change
NZX | ASX - SHINTR
Announcement
20.1.2021
SPH Notice – Masfen Securities Limited and Others
NZX - SHINTR
Announcement
11.1.2021
Capital Change Notice
NZX - SHINTR
Announcement
11.1.2021
Substantial Shareholder Notice – Browns Island Holdings Limited
NZX - SHINTR
Announcement
11.1.2021
Substantial Shareholder Notice – Consolidated Nominees Pty Ltd
NZX - SHINTR
Announcement
8.1.2021
Change of Director’s Interest Notice
ASX - Change of Director's Interest Notice
Announcement
6.1.2021
Annual Report for the year ended 31 March 2020
ASX - Period Reports | ASX Admission to Official List
Announcement
5.1.2021
Top 20 Shareholders List
ASX - Top 20 Shareholders | Admission to Official List
Announcement
5.1.2021
Distribution Schedule
ASX - Issued Capital | Admission to Official list
Announcement
5.1.2021
Reviewed pro-forma statement of financial position
ASX - Period Reports | Admission to Official list
Announcement
5.1.2021
Accounts for the six months ended 30 September 2020
ASX - Periodic Reports | Admission to Official List
Announcement
5.1.2021
Annual Report for the year ended 31 March 2019
ASX - Period Reports | Admission to Official List
Announcement
5.1.2021
Constitution
ASX - Admission to Official List | Constitution
Announcement
5.1.2021
Information Form and Checklist Annexure 2
ASX - Admission to Official List | Company Administration - Other
Announcement
5.1.2021
Information Form and Checklist
ASX - Admission to Official List | Company Administration - Other
Announcement
5.1.2021
Appendix 1C
ASX - Issued Capital - Other | Admission to Official list
Announcement
5.1.2021
ASX Market Announcement – Admission and Quotation
ASX - Admission to Official List | Commencement of Official Quotation
Announcement
22.12.2020
Offer Closes Significantly Oversubscribed
NZX - OFFER
Announcement
15.12.2020
ASX Approves TruScreen to Official List – Offer to Close 18 December 2020
NZX - OFFER
Announcement
9.12.2020
Public Offer Acceptance Reaches Target NZ$1.5 Million
NZX - OFFER
Announcement
26.11.2020
Opening of Public Offer and Publication of Research Report
NZX - OFFER
Announcement
9.11.2020
Application for Dual Listing of TruScreen’s Shares on the ASX
NZX - GENERAL
Announcement
4.11.2020
TruScreen Unaudited Interim Condensed Financial Statements 30 September 2020
NZX - INTERIM
Announcement
4.11.2020
TruScreen Results Template 30 September 2020
NZX - INTERIM
Announcement
4.11.2020
TruScreen Results Half Year Ended 30 September 2020
NZX - INTERIM
Announcement
21.9.2020
Recording of TruScreen Group Limited ASM Virtual Meeting
NZX - MEETING
Announcement
11.9.2020
Annual Meeting of Shareholders Results
NZX - MEETING
Announcement
11.9.2020
Juliet Hull Elected Non-Executive Director
NZX - ADMIN
Announcement
5.8.2020
Truscreen Strengthens Market Presence in Central Europe
NZX - GENERAL
Announcement
20.7.2020
Truscreen Director Nominations Closing Date
NZX - MEETING
Announcement
13.7.2020
Truscreen Stakeholders Newsletter July 2020
NZX - GENERAL
Announcement
29.6.2020
Truscreen NZX Results Announcement Form March 2020
NZX - ANNREP
Announcement
26.6.2020
Truscreen Financial Results for the year ended 31 March 2020
NZX - ANNREP
Announcement
5.6.2020
Truscreen Capital Change Notice
NZX | Truscreen-Capital-Change-Notice
Announcement
4.6.2020
Truscreen Priority Allocation of $1 Million Closed
NZX - OFFER
Announcement
29.5.2020
Results Announcement Date – Reliance on NZX Class Waiver
NZX - GENERAL
Announcement
29.5.2020
Truscreen Capital Change Notice
NZX - SECISSUE
Announcement
25.5.2020
Director Disclosure Notices
NZX - SHINTR
Announcement
22.5.2020
Truscreen Closes Public Pool Offer Fully Subscribed
NZX - OFFER
Announcement
21.5.2020
Director’s Certificate
NZX
Announcement
21.5.2020
Truscreen Limited Capital Change Notice
NZX
Announcement
18.5.2020
TruScreen Key Investment Highlights
NZX - OFFER
Announcement
18.5.2020
Notice of Offer of Same Class Financial Products for Issue
NZX - OFFER
Announcement
6.5.2020
Truscreen expands in China
NZX - MKTUPDTE
Announcement
28.4.2020
Truscreen Limited Corporate Action Notice
NZX - GENERAL
Announcement
28.4.2020
Offer Booklet
NZX - OFFER
Announcement
28.4.2020
Truscreen Investor Presentation
NZX - SHINTR
Announcement
20.4.2020
TruScreen expands to Vietnam with Ministry of Health Approval
NZX- GENERAL
Announcement
17.2.2020
Appointment of Auditors
NZX - AUDITORS
Announcement
17.2.2020
TruScreen Appoints Ex-Johnson & Johnson UK Executive as CEO
NZX - GENERAL
Announcement
11.2.2020
TruScreen Manufacturing and Supply Chain Update
NZX - GENERAL
Announcement
14.1.2020
Outstanding Results from Truscreen Indian Screening Trial
NZX - GENERAL
Announcement
28.11.2019
TruScreen Unaudited Preliminary Results for the Half Year Ending 30 September 2019
Announcement
28.11.2019
TruScreen Interim Results to 30 September 2019
Announcement
26.11.2019
November 2019 Newsletter
Announcement
10.10.2019
WHO cervical cancer elimination strategy opens up TruScreen’s market opportunity
Announcement
30.9.2019
Interim Unaudited Financial Statements
Announcement
27.9.2019
Resignation of Chief Executive Officer
Announcement
25.9.2019
Unlisted Options Issue
Announcement
24.9.2019
Director and Officer Disclosure Notices
Announcement
3.9.2019
Issue of Securities
Announcement
2.9.2019
Screening results in Hunan, China exceed expectations
Announcement
2.9.2019
Director Ongoing Disclosure Notice
Announcement
30.7.2019
TRU July Newsletter
Announcement
12.7.2019
TruScreen Director’s Certificate
Announcement
12.7.2019
TruScreen Share Issue
Announcement
12.7.2019
TruScreen Director Nominations Closing Date
Announcement
9.7.2019
TruScreen Completes Capital Raising
Announcement
9.7.2019
Memorandum
Announcement
2.7.2019
TruScreen Trading Halt
Announcement
1.7.2019
TruScreen Limited 2019 Annual Report
Announcement
20.6.2019
TruScreen Market Update
Announcement
12.6.2019
Cervical Cancer Technology Landscape – Unitaid & WHO Publication
Announcement
30.5.2019
Preliminary Financial Statements
Announcement
30.5.2019
TruScreen FY19 results show sales up, costs down, reduced loss
Announcement
30.5.2019
TruScreen Preliminary Results FY19 Appendix
Announcement
28.5.2019
World Health Organisation Recognises TruScreen Cervical Cancer Screening Device
Announcement
8.3.2019
Investor Update
Announcement
7.3.2019
Market Update – March 2019
Announcement
14.12.2018
TruScreen Significant Sales Increase, Reduced Loss in Half Year
Announcement
14.12.2018
TruScreen Preliminary Results
Announcement
14.12.2018
TruScreen Interim Results to 30 Sept 2018
Announcement
5.12.2018
Waivers and Rulings for Migration to NZX Main Board
Announcement
5.12.2018
L&Q Notice: TruScreen Limited Ordinary Shares (“TRU”)
Announcement
4.12.2018
TruScreen December Newsletter
Announcement
28.11.2018
TRU Migration from NZAX Market to NZX Main Board
Announcement
15.11.2018
TRU Appoints CFO and Company Secretary
Announcement
19.10.2018
TRU Appointment of Alternate Director
Announcement
16.10.2018
TruScreen Reports 523% Sales Growth for First Half Year
Announcement
4.10.2018
TruScreen Announces New Chairman
Announcement
27.9.2018
Shareholder Presentation Annual Meeting 2018
Announcement
27.9.2018
TruScreen Annual Meeting
Announcement
27.9.2018
TruScreen’s Annual Meeting – Chairman’s Presentation
Announcement
27.9.2018
Results of Annual Shareholder Meeting
Announcement
17.9.2018
TruScreen Share Purchase Plan Details
Announcement
14.9.2018
TruScreen HIV African Initiative Update
Announcement
14.9.2018
TruScreen Announces Share Purchase Plan Details
Announcement
6.9.2018
Director’s Resolutions
Announcement
6.9.2018
TruScreen Share Placement September 2018
Announcement
31.8.2018
TRU Capital Raising August 2018
Announcement
27.8.2018
TruScreen Announces HIV African Initiative
Announcement
31.7.2018
Truscreen Limited – 2018 Annual Report
Announcement
31.7.2018
2018 Annual Review Letter
Announcement
31.7.2018
TruScreen Limited: Annual Report and Section 209C Notice
Announcement
25.7.2018
TruScreen Commences Large Scale Chinese Pilot with CDC
Announcement
16.7.2018
TruScreen’s New Production Facility Fully Operational & Delivers Significant Improvement In Device Profitability
Announcement
4.7.2018
TruScreen Makes Strong Progress in First Quarter FY19
Announcement
14.6.2018
Preliminary Consolidated Financial Statements NZX Appendix
Announcement
14.6.2018
Preliminary Consolidated Financial Statements
Announcement
14.6.2018
TruScreen Unaudited Preliminary Results for the Year Ended 31 March 2018
Announcement
6.6.2018
TruScreen June Newsletter
Announcement
2.6.2018
Cancer Marketing Expert Joins TruScreen Board
Announcement
31.1.2018
TruScreen Appoints New Director
Announcement
31.1.2018
TruScreen Half Year Report and Interim Financial Statements
Announcement
31.1.2018
TruScreen January Newsletter
Announcement
20.12.2017
Resignation of Director
Announcement
6.12.2017
TruScreen Receives CFDA Approval for its Second Generation Device in China
Announcement
24.11.2017
TruScreen Passes CFDA Technical Assessment for its Second Generation Device in China
Announcement
20.10.2017
World-renowned medical specialist joins TruScreen Board 19 October 2017
Announcement
27.9.2017
Annual Meeting of Shareholders
Announcement
22.8.2017
TruScreen Director Nominations Closing Date
Announcement
1.8.2017
TruScreen Annual Report 2017
Announcement
15.6.2017
TruScreen Preliminary Results for the Year Ended 31 March 2017
Announcement
15.6.2017
TruScreen Limited Preliminary Consolidated Financial Statements
Announcement
15.6.2017
TruScreen Limited NZX Appendix 1 Release
Announcement
19.4.2017
TruScreen April 2017 Newsletter
Announcement
7.3.2017
TruScreen Investor Briefing Presentation March 2017
Announcement
14.12.2016
TruScreen Interim Results to 30 September 2016
View TruScreen Group Limited’s financial reports
ReportsLearn more about TruScreen’s team
Our People